glp-1 for psoriatic arthritis The list of conditions which drugs provide benefit independent of weight loss keeps growing. Add #AAD26 @AADskin The list of conditions for
Description
Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrom...

rhamnosus GG (Heat-inactivated)

While their glycemic, weight-lowering, and cardiovascular benefits are well established through randomized trials and meta-analyses, concerns remain regarding their safety and tolerability across diverse populations and clinical settings
Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular benefits in type 2 diabetes, but none of the cardiovascular trials studied atrial fibrillation/atrial flutter (AF) as a primary endpoint

Ozempic, zellikle tip 2 diyabet hastalarnda kan ekeri kontroln salamak amacyla kullanlan bir ilatr
